Boston Oncology
Navaneetha Selvan currently serves as the Head of Regulatory Affairs & Pharmacovigilance at Boston Oncology since September 2024. Prior to this role, Navaneetha held the position of Associate Vice President - Global Regulatory Affairs (Biotech) at Wockhardt Ltd. from April 2017 to August 2024, where responsibilities included managing global regulatory submissions for biosimilars and biological products. Navaneetha's career also includes significant experience at Biocon Biologics as Senior Director of Regulatory Sciences, focusing on biosimilars and managing regulatory filings for various biological products. Earlier roles at Shasun Pharmaceuticals Limited and Dr. Reddy's Laboratories involved oversight of global regulatory filings and strategic input for development products. Navaneetha holds a PhD in Pharmaceutical Sciences from Bundelkhand University, a Postgraduate Degree in Pharmaceutical Technology from Vinayaka Mission's Research Foundation, and a Bachelor's degree in Pharmacy from Dr. MGR Medical University.
This person is not in any teams
This person is not in any offices
Boston Oncology
Bold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development, manufacturing and distribution of US- quality medicines – across therapeutic areas. From our nerve center in Riyadh, we leverage the expertise, daring creativity, and unwavering determination of our international leadership team to provide customers with end-to-end, efficient, single-point-of-contact access to our diverse portfolio of world-class biogenerics. We do this because lives depend on it.